RandallRStoltzMD

Medical Director at Indiana University

Dr. Stoltz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
801 Saint Marys Dr
Ste 110E
Evansville, IN 47714
Phone+1 812-485-1895

Fax+1 812-485-1844

Staccato Loxapine Single Dose PK Start of enrollment: 2005 Sep 01
Completed
Phase 1
Staccato Alprazolam Single Dose PK Start of enrollment: 2005 Jun 01
Completed
Phase 1
Staccato Prochlorperazine Thorough QT/QTc Start of enrollment: 2007 Oct 01
Completed
Phase 1
Staccato Loxapine PK in Smokers and Nonsmokers Start of enrollment: 2009 Apr 01
Completed
Phase 1
Staccato Loxapine Thorough QT/QTc Study Start of enrollment: 2009 Apr 01
Completed
Phase 1
Join now to see all

PubMed

10 citations
Safety, Pharmacokinetics, and Pharmacodynamics of Trazpiroben (TAK-906), a Novel Selective D 2 /D 3 Receptor Antagonist: A Phase 1 Randomized, Placebo-Controlled Singl...
Roger Lewis Whiting, Borje Darpo, Chunlin Chen, Margaret S. Fletcher, Dan Combs
Clinical Pharmacology in Drug Development. 2021-01-18
50 citations
CK-2127107 amplifies skeletal muscle response to nerve activation in humans.
Jinsy A. Andrews, Timothy M. Miller, Vipin Vijayakumar, Randall Stoltz, Joyce K. James
Muscle & Nerve. 2018-05-01
16 citations
A Randomized Phase 1 Dose Escalation Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Trabodenoson in Healthy Adult Volunteers.
Alan M. Laties, Cadmus C Rich, Randall Stoltz, Vernon Humbert, Chaim Brickman
Journal of Ocular Pharmacology and Therapeutics. 2016-10-01